INTRODUCTION
============

Recent discoveries of a growing number of non-protein coding RNAs (npcRNAs) in bacteria have challenged the previous impression that proteins are the only relevant players in the control of bacterial gene expression. Bacterial small npcRNAs constitute a structurally diverse class of molecules that are typically 50--200 nt long and play a crucial role in many cellular networks, including responses to environmental stress, plasmid and viral replication, quorum sensing and bacterial virulence ([@B1; @B2; @B3; @B4; @B5; @B6; @B7; @B8; @B9]). The majority of known bacterial npcRNAs regulate gene expression by base pairing with mRNAs acting in *trans-* or *cis-*, and thereby either activating or repressing translation efficiency or the stability of the mRNA targets. Another subclass of *cis*-encoded riboregulators are located in the 5′-untranslated regions (UTR) of mRNA and are termed riboswitches ([@B10]), and facilitate feedback regulation at the transcription/translation level, following structure changes in the RNA in response to the binding of the metabolites.

*Salmonella* is categorized under the family of Enterobacteriaceae that includes the group of enteric bacteria. Based on DNA sequences, the *Salmonella* genus includes two species, *S. enterica* and *S. bongori* that are further subdivided into subspecies and serovars (\>2500 serovars). *Salmonella enterica* serovar Typhi (hereafter referred to as *S. typhi*) is a Gram-negative, human-specific pathogen causing enteric typhoid fever, an acute life-threatening febrile illness that affects the reticuloendothelial system. According to the World Health Organization, 16--33 million cases and 500 000--600 000 deaths are reported around the world annually. *S. typhi* is characterized by its flagellar H-antigen, its lipopolysaccharidic O-antigen and its polysaccharide capsular virulence antigen found at the surface of freshly isolated strains.

The genome of *S. typhi* strain Ty2 was recently sequenced ([@B11]). It has a single 4.8-Mb chromosome with an average G+C content of ∼52% and encodes 4339 genes of which more than 200 are functionally inactive. Unlike the multidrug resistance (MDR) strain *S. typhi* CT18, *S. typhi* Ty2 has no plasmids and is sensitive to antibiotics. Comparisons of *S. typhi* isolates from around the globe indicated that they are highly related and can be traced to a single point of origin ∼30 000--50 000 years ago ([@B12]). Only ∼10% of the core genes are not shared between *Escherichia coli* and *S. enterica*, suggesting that they most likely branched from a common ancestor over 100 million years ago ([@B12]). A genome comparison with the *S. typhi* CT18 strain demonstrated a remarkable degree of conservation; one of the more interesting differences being an additional cluster of a few genes in Ty2 that may be a novel Salmonella Pathogenicity Island (SPI) ([@B11]). There are 10 SPIs (SPI-1--10) presently known in the *S. typhi* genome, all of which are thought to be involved in the virulence of the pathogen.

One of the key features of *S. typhi* is its restriction to human hosts, which has inhibited direct studies of its pathogenicity. Instead, much has been learned from comparative research with its close serovar, *S. typhimurium* in the mouse model. A number of npcRNAs involved in different regulatory pathways were identified in *S. typhimurium*, including SPI-1-derived InvR npcRNA. Surprisingly, InvR is not functionally linked to SPI-1 secretion or invasion pathways, but instead regulates the expression of OmpD porin ([@B13]). Padalon-Brauch *et al.* ([@B14]) identified and characterized 19 novel npcRNAs encoded by genes in the SPIs of *S. typhimurium* that possibly function in the pathogenicity of the bacterium. Using high-throughput pyrosequencing, Sittka *et al.* ([@B15]) detected 65 npcRNA candidates in *S. typhimurium*, many of which are conserved in *S. typhi* and related pathogenic enterobacterial species ([@B16],[@B17]) and may function in complex with the Hfq protein. A number of characterized, *trans*-encoded RNAs in bacteria require the Sm-like RNA chaperone Hfq for regulating the translation of their mRNA targets. Hfq binds with high affinity to OxyS, DsrA, RprA, RyhB, Spot42, SgrS and other npcRNAs identified in *E. coli* and is frequently required for both their intracellular stability and interaction with target mRNAs ([@B18; @B19; @B20]), either to activate or predominantly to silence translation ([@B21]). Deletion of Hfq in *S. typhimurium* attenuates its ability to infect mice and especially to invade epithelial cells, indicating that Hfq and its ribonucleoprotein particle (RNP) complexes are essential for the virulence of the bacterium ([@B5]). Expression of Hfq is also essential for the virulence of *Shigella flexneri* ([@B22]).

Recently, the *S. typhi* transcriptome was analyzed using Illumina-platform high-throughput sequencing, whereby 40 putative npcRNAs were identified ([@B23]); surprisingly, only five of them were also found in common with those in *S. typhimurium* ([@B15],[@B23]). Transcriptome analyses also revealed the presence of *cis*-encoded npcRNAs expressed in antisense orientation to open reading frames (ORFs) of bacterial genes ([@B24; @B25; @B26]). Although many of the reported examples negatively regulate expression of the complementary mRNAs, some of them (like GadY) increase the stability of the corresponding mRNAs ([@B27]).

To survey the population of npcRNAs in *S. typhi*, we generated a specialized cDNA library representing three different growth stages of the bacterium. We experimentally identified and characterized many novel npcRNA candidates. Their differential expression patterns were compared with potential homologs in *E. coli*. Many of the npcRNA candidates are restricted to *Salmonella* species or to *S. typhi* and some of the npcRNA candidates may be involved in the MDR of *S. typhi*.

MATERIALS AND METHODS
=====================

*S. typhi* culture conditions
-----------------------------

*S. typhi* was cultured in Luria-Bertani medium (LB); 100 μl of a clinical isolate of *S. typhi* from glycerol stock was aseptically inoculated into 10 ml of LB medium and incubated overnight at 37°C with 220 rotations per minute. LB medium (250 ml) was then inoculated with a 2.5 ml aliquot of the overnight culture. Cells were harvested during the lag phase (OD~600~ 0.3--0.4), log phase (OD~600~ 0.6--0.7) and stationary phase (OD~600~ 1.5). Total RNA was extracted by Trizol reagent (Gibco BRL) according to the manufacturer's instructions.

cDNA library construction
-------------------------

To avoid unintended bias in our starting material, equal amounts of total RNA (50 μg) extracted from different growth stages of *S. typhi* were combined, size fractionated (20--500 nt) on 8% denaturing PAGE gels (7 M urea, 1 × TBE buffer) and passively eluted in 0.3 M NaOAc (pH 5.3) overnight at 4°C. Size-selected RNA was ethanol precipitated. All further steps of library construction were performed as described by Raabe *et al.* ([@B28]). The resulting 1700 cDNA clones were randomly sequenced and assembled into contigs. All cDNAs shorter then 18 nt were excluded from further analysis. The resulting 388 contigs were manually analyzed and mapped to the *S. typhi* Ty2 genome (AE014613) using BLAST (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) and BLAT (<http://archaea.ucsc.edu/cgi-bin/hgBlat>) genomic browsers.

Northern blot analysis
----------------------

Total RNA (8--10 μg) was separated on 8% denaturing polyacrylamide gels and electro-transferred onto positively charged nylon membranes (Ambion Ltd). Northern blot analyses using specific oligonucleotides ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)) complimentary to putative npcRNAs were performed as described by Khanam *et al.* ([@B29]).

Cloning and purification of recombinant RamR and Hfq proteins from *S. typhi*
-----------------------------------------------------------------------------

DNA fragments representing the ORFs of *ramR* and *hfq* protein-coding genes from *S. typhi* were generated by PCR amplification of genomic DNA. The reaction was performed using a standard protocol ([@B30]), and oligonucleotides RamRndeIF and RamRxhoIR (for *ramR*), and HfqforvndeI and HfqrevxhoI (for *hfq*) ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). To facilitate cloning, NdeI and XhoI restriction sites were introduced into the oligonucleotide sequence. The pET28-b+ vector was used for cloning and expression of RamR and Hfq proteins. The expected clones were confirmed by sequence analysis. The recombinant RamR and Hfq proteins were purified from *E. coli* BL21 cells as instructed by the manufacturer (Qiagen). The proteins were dialyzed against buffer containing 20 mM HEPES--KOH (pH 7.4), 150 mM KCl, 1.5 mM MgCl~2~ and 5% glycerol.

RNA gel shift assay
-------------------

For binding assays to RamR or Hfq protein, *S. typhi* novel npcRNA candidates were *in vitro*-transcribed from PCR templates containing a T7 promoter using 250 U of T7 RNA polymerase, and gel-purified npcRNAs were radioactively labeled by incorporating \[α-^32^P\] UTP during the *in vitro* transcription. Before incubating with recombinant RamR or Hfq protein, RNAs were dissolved in buffer containing 20 mM HEPES-KOH (pH 7.4), 80 mM NaCl, 10 mM KCl, 2.5 mM MgCl~2~, heat-denatured (2 min at 85°C) and subsequently placed in ice. RNP complexes of recombinant RamR or Hfq proteins with npcRNAs were formed in reaction volumes of 20 μl containing 20 mM HEPES--KOH (pH 7.4), 80 mM NaCl, 10 mM KCl, 2.5 mM MgCl~2~, 2 mM DTT, 10% glycerol, 1 μg BSA, 5 μg tRNA and 5 U of ribonuclease inhibitor (RNasin, Fermentas); 2 μg of sheared salmon sperm DNA was added for the RamR protein binding assay. Aliquots (0.05 pmol) of npcRNAs were incubated with increasing concentrations of RamR or Hfq for 30 min at room temperature. RNA and RNA--protein complexes were separated on native 8% (w/v) polyacrylamide gels containing 1 × TBE (90 mM Tris; 64.6 mM boric acid; 2.5 mM EDTA; pH 8.3). All further steps were performed as described by Rozhdestvensky *et al.* ([@B31]). The apparent K50 values of the RNA--protein complexes were defined as the protein concentrations for which 50% of the input RNA was shifted to an RNP complex.

DNA gel shift assay
-------------------

For binding assays to RamR protein, two complementary 60-nt oligonucleotides harboring the promoter region of the *S. typhi ramA* gene were synthesized (MWG Biotech, Ebersberg, Germany) ([Figure 3](#F3){ref-type="fig"}A; [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). As controls, oligonucleotides harboring 9-nt and 2-nt deletions were also generated ([Figure 3](#F3){ref-type="fig"}A, [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1); 32,33). Complementary single-stranded DNA fragments were end-labeled with \[γ-^32^P\]-ATP using T4 polynucleotide kinase and annealed. The resulting double-stranded DNA fragments were gel-purified from native 10% (w/v) polyacrylamide gels containing 1 × TBE and passively eluted in 0.3 M NaOAc (pH 7.0) and 1 mM EDTA buffer at 4°C overnight.

Complexes of recombinant RamR protein with DNA fragments (∼0.05 pmol per reaction) were formed in a volume of 20 μl containing 20 mM HEPES--KOH (pH 7.4), 80 mM NaCl, 10 mM KCl, 2.5 mM MgCl~2~, 2 mM DTT, 10% glycerol, 1 μg BSA, 5 μg tRNA, 2 μg of sheared salmon sperm DNA and 5 U of ribonuclease inhibitor (RNasin, Fermentas) ([Figure 3](#F3){ref-type="fig"}B). The subsequent steps were performed as described above for RNA gel shift assays.

Gel shift competition assays
----------------------------

Competition assays were performed under the above binding conditions with 300 nM RamR protein and increasing concentrations of DNA fragments or *S. typhi* StyR-3 npcRNA as competitors ([Figure 3](#F3){ref-type="fig"}D). All reactions were incubated for 30 min at room temperature. DNA and DNA-protein complexes were separated on native 10% (w/v) polyacrylamide gels containing 1 × TBE buffer. Electrophoresis and subsequent steps were performed as described above.

Oligonucleotides used in this work
----------------------------------

All oligonucleotides used in this work are listed in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1).

RESULTS AND DISCUSSION
======================

cDNA library construction and analysis
--------------------------------------

To survey the population of npcRNAs in *S. typhi*, we generated a specialized cDNA library representing the lag, log and stationary growth stages of the bacterium. A total of 1700 cDNA clones were randomly sequenced and assembled into contigs. All cDNAs shorter than 18 nt were excluded from further analysis. The resulting 388 contigs were manually analyzed and mapped to the *S. typhi* Ty2 genome (AE014613) using BLAST (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) and BLAT (<http://archaea.ucsc.edu/cgi-bin/hgBlat>) genomic browsers. To identify known npcRNAs in our data set, we screened cDNA sequences against known npcRNAs in *Salmonella* and *E. coli*. Nearly half of the cDNAs were derived from the highly abundant npcRNA species of rRNAs (22%) and tRNAs (25%) ([Figure 1](#F1){ref-type="fig"}A). Roughly 5% of the cDNA sequences belonged to other known npcRNAs ([Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). cDNAs that mapped to the ORFs of known or hypothetical protein-coding genes constituted the largest subgroup (27%). Some of these cDNAs might represent potential npcRNA species that overlap with ORFs, similar to RNAIII, a small npcRNA in *S. aureus* ([@B34]). Moreover, the predicted ORFs of the hypothetical protein-coding genes matching some of the cDNAs may be wrongly annotated and may encode potential novel npcRNAs instead ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Furthermore, some of those candidates overlap with putative 5′-UTR regions and may represent the products of transcriptional attenuation and correspond to potential candidates for novel riboswitches ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Figure 1.Classification of cDNA sequences and identified novel npcRNA candidates. (**A**) Distribution of the cDNA sequences among various classes of RNA species; frequencies indicated as percentages. (**B**) Classification and expression profiles of novel npcRNA candidates in *S. typhi* and their *E. coli* homologs.

Interestingly, 21% of the cDNAs could not be assigned to any known RNAs, and thus represent candidates for novel npcRNAs in *S. typhi* ([Figure 1](#F1){ref-type="fig"}A and B). Eight of these 97 npcRNA candidates overlap with those identified by Perkins *et al.* ([@B23]) via deep sequencing. As mentioned above, deep sequencing approaches in the closely related *S. typhimurium* and *S. typhi* species also revealed only 5 putative npcRNAs in common ([@B15],[@B23]). Such a paucity of overlap was also observed in our laboratory in another instance where two different sequencing approaches were available for the same or similar RNA preparations (our unpublished data). Most likely, the differences are a consequence of alternative methodologies for preparing RNAs for cDNA libraries and for sequencing (e.g. pre-selections, tailing, linker ligation and PCR amplification). Hence, comparisons between two data sets are valid only when generated with virtually identical experimental approaches. These observations are a clear warning that even deep sequencing is unlikely to represent all RNA species, the identification of which may require a combination of various approaches.

Potential candidates for novel npcRNAs in *S. typhi*
----------------------------------------------------

The 97 npcRNA candidates that we identified experimentally ([Figure 1](#F1){ref-type="fig"}B) have been assigned reference identifications based on the template, StyR-*n* (*S. typhi* npcRNA - number). Three of the npcRNA candidates are specific to *S. typhi* and 22 are restricted to *Salmonella* species; of these three are restricted to *S. typhi* and *S. paratyphi* C and one to *S. typhi* and *S. paratyphi* A. Most of our npcRNA candidates are transcribed complimentarily to ORFs of known or hypothetical protein-coding genes (39 candidates, [Figure 1](#F1){ref-type="fig"}B), supporting previous experimental evidence of significant antisense transcription in bacteria ([@B35],[@B36]). Twenty-four npcRNA candidates were mapped to intergenic regions of the *S. typhi* genome ([Figure 1](#F1){ref-type="fig"}B). Given that most known npcRNAs in bacteria were previously identified and characterized in *E. coli* and the close phylogenetic relationship between *S. typhi* and *E. coli* (60--70% genomic similarity), we computationally predicted the existence of 63 putative homologous and novel npcRNAs that we designated as EcoR (*Escherichia coli* npcRNA- number).

Expression analysis of novel StyR npcRNAs
-----------------------------------------

To determine the differential expression of our npcRNA candidates and to validate our computational analysis, we performed northern blot hybridizations on total RNA samples from three different bacterial growth stages. To ensure specific detection of npcRNA candidates, we designed a second oligonucleotide probe complementary to the respective RNA sequence in most of the cases ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Approximately 45% of the npcRNA candidates were detected on northern blots ([Figure 1](#F1){ref-type="fig"}B). Many of these transcripts exhibited the same length as the corresponding cDNA sequence contigs, leading us to conclude that our technique for constructing the bacterial cDNA library often yields full-length npcRNAs. However, in a few cases, the resulting northern blot signals suggested longer RNAs than the cDNAs predicted. Differential expression analyses of the npcRNA candidates indicated that the majority of them were regulated in a growth-dependent manner in S*. typhi*. To confirm the validity of the 63 putative npcRNAs orthologs predicted in *E. coli*, we carried out northern blot analysis with *E. coli* total RNA isolated from three different growth stages in parallel*.* Northern blot signals supported the phylogenetic predictions for 19 of these npcRNA homologs ([Figures 2](#F2){ref-type="fig"}, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}B and [6](#F6){ref-type="fig"})

Based on their genomic localization and orientation, we grouped the novel npcRNA candidates into four classes: (i) intergenic npcRNAs; (ii) antisense npcRNAs; (iii) repetitive npcRNAs; and (iv) npcRNAs partially overlapping with ORFs ([Figure 1](#F1){ref-type="fig"}B). To a large degree, however, these classifications were somewhat arbitrary, chiefly due to incomplete annotations of the genome. For example, with regard to the intergenic regions (Class 1), there are no annotations for 5′- and 3′-UTRs, because very few experimental data are available. An intergenic RNA might simply be derived from a UTR representing a more stable domain of an mRNA. Furthermore, the promoter-associated npcRNAs (Class 1.1) and terminator-associated npcRNAs (Class 1.2) are, strictly speaking, not intergenic and in many cases might be more appropriately classified as 5′- and 3′- UTR-associated or -derived RNAs, a definition that would also include riboswitches. The same difficulty arises for npcRNAs that map between genes in an operon (Class 1.3). Only the individual genes (Class 1.4) may be truly intergenic. On the other hand, npcRNAs located in a sense or antisense orientation to hypothetical ORFs might also be truly intergenic npcRNAs. The candidates located in a sense orientation to ORFs are listed in [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1) and are marked as being derived from hypothetical ORFs to discriminate them from sense RNAs located within proven ORFs, as the majority of the latter merely represent more stable degradation products of *bona fide* mRNAs.

Class 1: novel npcRNA candidates from intergenic regions of *S. typhi*
----------------------------------------------------------------------

Obviously, intergenic regions remain the 'hot spot' for computational searches of npcRNAs. In fact, a number of previous predictions were focused solely on intergenic regions of bacteria ([@B37; @B38; @B39]). However, the intergenic npcRNA candidates that harbor low phylogenetic conservation or do not encode conserved secondary structures might not be detected in computational screens. Moreover, in some cases, the criterion of sequence conservation alone is insufficient and could be misleading. This might be particularly important for evolutionarily young and probably species-specific npcRNAs that nevertheless might exert important functions. Our experimental approach uncovered 24 npcRNA candidates derived from intergenic regions of *S. typhi* and the expressions of 15 of them were monitored by northern blot analysis. The corresponding RNAs range in size from 32 to 212 nt and many of them show growth stage-specific expression ([Figure 2](#F2){ref-type="fig"}). We identified putative transcriptional regulatory elements (promoters and ρ-independent terminators) for five npcRNA genes from this category. However, their transcriptions might be more complex and some might be initiated from promoters of the adjacent genes. The intergenic npcRNAs were further subdivided into four categories depending on their location ([Table 1](#T1){ref-type="table"}). Figure 2.Expression analysis of intergenic-derived npcRNA candidates at different growth stages of *S. typhi* and *E. coli*. Northern blot analysis was performed on total RNA isolated from *S. typhi* and *E. coli* cultures at different OD~600~ values, as shown across the top of the blots. OD~600~ 0.3: lag phase-steady bacterial growth; OD~600~ 0.7: log phase-exponential bacterial growth; and OD~600~ 1.5: stationary growth phase. The npcRNA candidates and their sizes are indicated. As loading controls, a few examples of ethidium bromide-stained 5S rRNA are shown at the bottom of each panel. Table 1.Compilation of npcRNA candidates from intergenic regions in *S. typhi*npcRNAscDNA (nt)Orient.Adj. genes (ID)Presence in *E. coliN. Blot S. typhi* /*E. coli*Growth reg. *S. typhi* /E. coliSpecificityCommentsAcc. No.Promoter-associated npcRNAs    StyR-3144\< \< \>1067322/1069368No+/−−/−*Sal.* spFJ746361    StyR-894\> \> \>1069235/1069233Yes−/−−/−FJ746362    StyR-10147\< \< \>1067006/1067023Yes+/++/−FJ746363    StyR-88109\> \> \>1067919/1067920Yes+/−+/−FJ746366    StyR-9932\< \> \>1067609/1068774No−/−−/−*Sal.* spFJ746367    StyR-13472\> \> \>1069120/1069122No−/−−/−*Sal.* spFJ746369    StyR-241152\< \< \>1068271/1068273Yes+/++/+ρ-ind. term.FJ746373    StyR-262156\< \> \>1069506/1069507Yes−/−−/−FJ746374    StyR-28750\> \> \>1067282/1069315No−/−−/−*Sal.* spFJ746376    StyR-29359\< \> \>1070460/1070461Yes−/−−/−FJ746378    StyR-362141\< \> \>1070630/1070631No−/−−/−*Sal.* spρ-ind. term.FJ746382    StyR-38322\< \< \>1068808/1068821No−/−−/−*Sal.* spFJ746384Terminator-associated npcRNAs    StyR-16932\< \< \<1069647/1067454Yes+/++/+FJ746371    StyR-28844\> \> \<1070605/1070606Yes+/+−/−FJ746377Operon-derived npcRNAs    StyR-5577\< \< \<1068343/1071526Yes+/++/+FJ746364    StyR-12634\< \< \<1069335/1067249Yes+/++/+FJ746368    StyR-17577\> \> \>1069764/1069765Yes+/++/+FJ746372    StyR-280102\< \> \>1068036/1068041Yes+/++/+FJ746375    StyR-30628\> \> \>1071397/1071398No+/−+/−FJ746379    StyR-33340\< \< \<1067027/1067676No+/−+/−*S. typhi*FJ746380    StyR-35446\< \< \<1067015/1068236No−/−−/−*Sal.* spFJ746381Possible individual intergenic npcRNA genes    StyR-59162\> \< \<1068621/1068614No+/−−/−*S. typhi*ρ-ind. term.FJ746365    StyR-161132\> \< \>1068552/1069548No+/−+/−*S. typhi, S. para* Cρ-ind. term.FJ746370    StyR-38173\> \> \>1067420/1067421No+/−−/−*S. typhi*, *S. para* C and *S. dublin*ρ-ind. term.FJ746383[^3]

### Subclass 1.1: promoter-associated npcRNAs

The principle of transcriptional interference, also termed promoter occlusion, has been known for a long time in bacteria. It describes the regulatory interplay between two neighboring promoters. Transcription initiated by the upstream promoter inhibits transcriptional start of the downstream promoter ([@B40],[@B41]). Recently, the mechanisms of transcriptional control involving small npcRNAs associated with transcription start sites in higher eukaryotes were described ([@B42],[@B43]). In addition, there are reports indicating regulation of promoter activity by npcRNAs in yeast ([@B44],[@B45]). Therefore, the control of transcription by promoter-associated RNA transcripts might be of broad importance.

We identified 12 npcRNA candidates that are transcribed within conserved mRNA promoter regions. In addition, five of the promoter-associated npcRNAs contain putative transcription factor binding sites within their primary sequences. Interestingly, there are reports indicating that transcription factors other than those with DNA binding activity also interact with RNA molecules (for review see 46). In this scenario, the npcRNA involves not only *cis*-mediated promoter occlusion but also regulates transcription in *trans*.

StyR-3 is an example of a promoter-associated npcRNA candidate. The RNA is co-transcribed by the promoter of the *ramA* gene and shares its putative transcriptional start site ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}A). StyR-3 is likely a stable processing product derived from the RamA 5′-UTR. StyR-3 represents an abundant npcRNA species in our library, with 24 independent cDNAs. The northern blot signal is consistent with a stable 144-nt StyR-3 transcript ([Figure 2](#F2){ref-type="fig"}).

RamA protein was recently identified as an alternative global regulator and an activator of the MDR regulation cascade in *S. typhimurium*. Overexpression of RamA was associated with MDR also in *Enterobacter aerogenes, Klebsiella pneumonia* and *S. enterica* serovar Paratyphi B ([@B47; @B48; @B49]). Recent reports identified two deletions in the promoter region of *ramA* that remarkably enhanced transcription of *ramA*, and consequently the MDR of bacteria ([@B32],[@B33]). StyR-3 overlaps the location of these two deletions, suggesting the presence of important suppressive *cis*-acting elements within the region encoding the StyR-3. In addition, two inverted repeats, one of them overlapping with StyR-3, were predicted to be DNA binding sites for the local repressor, RamR ([Figure 3](#F3){ref-type="fig"}A; 32,33). RamR belongs to the TetR family of proteins and inactivation of its gene in a susceptible serovar of the *Typhimurium* strain resulted in an MDR phenotype ([@B32]). Several transcription regulatory proteins interact both with DNA and RNA ([@B46]). Hence, we investigated whether the RamR transcriptional repressor protein specifically binds to StyR-3 npcRNA. Figure 3.Gel retardation analysis of the interaction of RamR protein with *ramA* gene regulatory region and StyR-3. (**A**) Sequence of *ramA* regulatory region. The −35, −10 and RBS sequences are underlined. Predicted RamR--DNA binding sites are indicated with bold letters. The 2-bp (Δ2 bp DNA) and 9-bp (Δ9 bp DNA) deletions within the *ramA* regulatory region are boxed. The transcriptional start site is indicated by an arrow. Asterisks indicate the 5′- and 3′-nt for the DNA fragment (WT DNA) used in the gel retardation assay. The StyR-3 sequence is indicated with a dotted line. (**B**) Gel retardation analysis of the interaction of RamR protein with the *ramA* gene regulatory region, showing wild-type DNA fragment (left), 2-bp (middle) and 9-bp (right) deletion fragments. (**C**) Interaction of RamR protein with StyR-3. (B and C) 32P-labeled DNA fragments or StyR-3 were incubated with *S. typhi* recombinant protein RamR as follows: lane 1, no protein added; (B and C) lanes 2--8: 50, 100, 150, 200, 400, 600 and 800 nM RamR protein was added, respectively; (**D**) Competition assay. 32P-labeled WT DNA was competed from RamR--DNP complex with increasing concentrations of unlabeled StyR-3 (lanes 3--5: 50, 250 and 500 nM, respectively) and WT DNA (lanes 6--8: 50, 250 and 500 nM, respectively). DNA: competitor molar ratios for lanes 3 and 6; 4 and 7; 5 and 8 were: 1:20; 1:100 and 1:200, respectively.

First, we conducted a gel retardation assay to examine whether the predicted binding sites within the *ramA* regulatory region specifically interact with and form a stable deoxyribonucleoprotein (DNP) complex with RamR protein. The *in vitro*-synthesized DNA fragments harboring the proposed RamR binding sites were radioactively labeled and a gel retardation assay was performed using increasing concentrations of RamR protein (see 'Material and Methods' section; [Figure 3](#F3){ref-type="fig"}B). We detected formation of a stable DNP complex with an apparent K50 of 300 nM (complex formation was performed in the presence of vast excesses of non-specific DNA and RNA competitors [Figure 3](#F3){ref-type="fig"}B). To provide further evidence of the specificity of RamR recognition, we assayed DNA fragments harboring the aforementioned 2- and 9-bp deletions within the *ramA* regulatory region. As expected, we did not observe a mobility shift with mutant DNA when incubated with increasing concentrations of RamR protein ([Figure 3](#F3){ref-type="fig"}B). The loss of complex formation is consistent with overexpression of RamA and the MDR phenotype observed in *S. typhimurium* mutant strains ([@B32],[@B33]).

Next, we examined via a gel retardation assay whether StyR-3 is specifically recognized by and forms an RNP complex with RamR protein. The *in vitro* binding assay detected the formation of an StyR-3/RamR--RNP complex with an apparent K50 of 300 nM (again, complex formation was done in the presence of vast excesses of non-specific DNA and RNA competitors [Figure 3](#F3){ref-type="fig"}C). Thus, we demonstrated that RamR specifically interacts with DNA harboring the regulatory region for the *ramA* gene and with StyR-3 npcRNA. Moreover, both DNP and RNP complexes were formed with similar apparent K50 values ([Figure 3](#F3){ref-type="fig"}B and C).

We therefore investigated whether StyR-3 interferes with RamR-DNA binding activity using a competition binding assay with increasing concentrations of unlabeled StyR-3. Even low concentrations (1 pmol) of competing StyR-3 abolished RamR--DNA binding ([Figure 3](#F3){ref-type="fig"}D). Notably, similar results were observed when increasing concentrations of the same unlabeled wild-type DNA were added ([Figure 3](#F3){ref-type="fig"}D). In contrast, when we competed RamR-DNA complex formation with unlabeled DNA fragments harboring the 9-bp deletion within the RamR binding site, no competition was detected (data not shown). Our data suggest an involvement of StyR-3 in the regulation of RamR-DNA binding activity, which might consequently effect *ramA* gene expression and the MDR of *S. typhi.* Given the obvious medical importance of MDR, StyR-3 might be considered a potential drug target.

We also identified other npcRNA candidates that overlap with DNA binding sites for regulatory proteins: StyR-88 with IscR, StyR-241 with Ntrc, StyR-293 with FNR and StyR-287 with GadX ([Figure 2](#F2){ref-type="fig"}; [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). It will be interesting to examine whether these npcRNA candidates are specifically recognized by and form RNP complexes with the corresponding transcription factors. Alternatively, these npcRNA candidates may be involved in bacterial chromosome remodeling and consequently regulate promoter activity in *cis*.

### Subclass 1.2: terminator-associated npcRNAs

Terminator-associated npcRNA candidates are a subclass of small stable npcRNAs located in regions overlapping ρ-independent terminator signals. The two candidates of this class are transcribed in a sense orientation with respect to the corresponding mRNAs and are likely derived from their 3′-UTRs. StyR-169 is associated with the terminator of the hypothetical protein gene *yaiA*, and StyR-288 overlaps with the ρ-independent terminator signal of the putative-exported protein-coding gene *t0311* ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Northern blot analyses revealed that StyR-169 (32 nt) and StyR-288 (44 nt) are generated from longer primary transcripts that are subject to differential processing steps ([Figure 2](#F2){ref-type="fig"}).

### Subclass 1.3: operon-derived npcRNAs

This subgroup consists of npcRNA candidates that do not contain discernible transcription regulatory elements, are possibly transcribed as parts of operons, and undergo additional RNA processing steps for maturation. Seven such npcRNA candidates were identified and their expressions confirmed by northern blot hybridization. StyR-55 contains a sequence motif that is essential for translational feedback regulation and efficient translation of *L10* and *L12* ribosomal protein-coding mRNA from the L10 operon ([Figure 2](#F2){ref-type="fig"}; [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Proteins L10 and L12 form a complex that specifically interacts (if rRNA binding sites are saturated) with the 5′-leader sequence of the L10 operon mRNA and prevents translation ([@B50]). StyR-55 harbors the unique binding site for the inhibitory L10/L12 complex. Expression of this candidate npcRNA was detected only in the stationary phase of *S. typhi* growth ([Figure 2](#F2){ref-type="fig"}). StyR-55, as an RNP with L10/L12 proteins, might participate in regulation of the L10 operon, be involved in a yet unknown function or both. Similarly, in *E. coli*, the t44 npcRNA was recently identified in an analogous region of the *rps2* gene, encoding ribosomal protein S2. The t44 npcRNA was proposed to play a role in attenuating *rps2* gene expression ([@B51]). An additional novel npcRNA candidate from *S. typhi*, StyR-8, originating from the leader sequence of the *rmpB* gene encoding ribosomal protein L28, was identified in our study ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). This finding might provide new insight into the regulation of ribosomal protein-coding gene expression. Future experimentation will determine whether, due to their stable structures and bound proteins, such RNAs are simply more stable degradation products of the transcribed operons or true functional riboregulators.

### Subclass 1.4: possible individual npcRNA genes

This category contains npcRNA candidates that are transcribed from intergenic regions of the *S. typhi* genome and for which associated regulatory elements (promoter and ρ-independent/intrinsic terminator) were predicted computationally. However, the situation might be more complex; for example, transcription might be initiated from promoters of adjacent genes. Three such npcRNA candidates were identified. Importantly, all of them were restricted to *Salmonella* serovars, representing evolutionarily young npcRNA species with potential strain-specific functions ([Table 1](#T1){ref-type="table"}; [Figure 2](#F2){ref-type="fig"}; [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Thus, StyR-381 is found in *S. typhi* and *S. dublin* genomes; StyR-161 is present in *S. typhi* and S paratyphi C; and StyR-59 is restricted to *S. typhi*.

Class 2: Antisense *S. typhi* npcRNAs
-------------------------------------

Small antisense npcRNAs have been studied in bacteria for over two decades and are classified according to their location on either chromosomal or plasmid DNA. Chromosomally encoded antisense npcRNAs are involved in diverse bacterial regulatory pathways. Generally, the functions of these RNAs are associated with transcriptional attenuation, inhibition of translation, or promotion of RNA degradation or cleavage ([@B52],[@B53]). Most of the chromosomally encoded antisense npcRNA genes are expressed only under certain conditions, for example, as *gadY* in a growth rate-dependent manner ([@B27]) or as *isrR* under stress conditions ([@B54]). The antisense npcRNAs are *cis*-encoded with perfect complementarity to large stretches of the corresponding target RNAs.

We identified 39 npcRNAs candidates derived from the strands of DNA complementary to protein-encoding genes (i.e. *cis*-encoded). In fact, they constituted the largest number of novel npcRNAs identified ([Table 2](#T2){ref-type="table"}). Of these, 24 npcRNA candidates have homologs in *E. coli* ([Table 2](#T2){ref-type="table"}) and 10 show growth stage-specific expression patterns in *S. typhi* ([Figures 1](#F1){ref-type="fig"}B and [4](#F4){ref-type="fig"}). Based on their location with respect to the ORF of the target genes, we established four subcategories. Table 2.Compilation of antisense npcRNA candidates in *S. typhi*npcRNAscDNA (nt)Orient.Gene (ID)Presence in *E. coliN. blot S. typhi* /*E. coli*Growth reg, *S. typhi* /*E. coli*SpecificityCommentsAcc. No.npcRNA candidates antisense to the 3′-end of ORF    StyR-143144\<1068407No−/−−/−*S. typhi*, *S. para* Aρ-ind. term.FJ746389    StyR-219104\>1068601Yes+/++/+ρ-ind. term.FJ746397    StyR-250222\>1069193Yes−/−−/−FJ746402npcRNA candidates antisense to the 5′-end of ORF    StyR-34149\>1070547No−/−−/−*Sal.* spFJ746419npcRNA candidates antisense to both 5′- and 3′-end of single ORF    StyR-281253\<1070369Yes+/−+/−FJ746407    StyR-47216\>Predicted ORFYes−/−−/−FJ746385npcRNA candidates antisense to both 5′- and 3′-end of ORFs    StyR-32878\<1068197Yes−/−−/−FJ746417    StyR-15046\>1067798/ 1067800No−/−−/−*Sal*. spFJ746390cis-encoded antisense npcRNA candidates to ORFs of protein-coding genes    StyR-10145\<1067667No−/−−/−*S. typhi*FJ746386    StyR-12225\>1069722Yes+/−−/−FJ746387    StyR-12883\<1069075Yes−/−−/−FJ746388    StyR-151109\>1067671Yes+/−−/−FJ746391    StyR-17257\<1069704Yes−/−−/−FJ746392    StyR-17376\<1068387No+/−+/−*Sal*. spFJ746393    StyR-17834\<1067312Yes−/−−/−FJ746394    StyR-19682\<1069862Yes+/−+/−FJ746395    StyR-19948\>1067680Yes+/−+/−FJ746396    StyR-22275\<1069061Yes−/−−/−FJ746398    StyR-234119\>1069670Yes+/++/+FJ746399    StyR-243135\>1069109Yes+/−+/−FJ746400    StyR-248211\>1070765Yes+/−+/−FJ746401    StyR-252162\<1071079Yes−/−−/−FJ746403    StyR-25498\<1071250Yes+/++/−FJ746404    StyR-26485\>1067864Yes+/+−/−ρ-ind. term.FJ746405    StyR-27799\>1069782Yes−/−−/−FJ746406    StyR-285110\<1070539No−/−−/−*Sal.* spFJ746408    StyR-29161\>1070390Yes−/−−/−FJ746409    StyR-29238\>1070899No−/−−/−*Sal.* spFJ746410    StyR-295109\>1066997Yes−/−−/−FJ746411    StyR-30222\<1067039No−/−−/−*Sal*. spFJ746412    StyR-30557\<1067199No−/−−/−FJ746413    StyR-30932\>1067690Yes−/−−/−FJ746414    StyR-31569\<1069646Yes−/−−/−FJ746415    StyR-32290\<1069020Yes−/−−/−FJ746416    StyR-336199\>1071148Yes−/−−/−FJ746418    StyR-358113\<1067275No+/−+/−*Sal.* spFJ746420    StyR-36922\<1067888No−/−−/−*Sal.* spFJ746421    StyR-37723\>1069015No−/−−/−FJ746422    StyR-37823\<1069059Yes−/−−/−*Sal*. spFJ746423[^4]

### Subclass 2.1: npcRNA candidates antisense to the 3′-end of ORFs

Three of the antisense npcRNAs (StyR-143, StyR-219 and StyR-250) partially overlap the 3′-ends of ORFs ([Table 2](#T2){ref-type="table"}; [Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). The *cis*-antisense candidate StyR-219 is complementary to the 3′-part of the ORF of *prfB* that encodes peptide chain release factor-2 ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). StyR-219 features a ρ-independent/intrinsic terminator and is conserved in many other enterobacteria. We computationally predicted an *E. coli* K12 homolog (EcoR-219) that shares 89% sequence similarity. Interestingly, the expression of the *E. coli prfB* gene is upregulated during later growth stages ([@B55],[@B56]), whereas the expression of StyR-219 is highest during the log phase of growth and expressions of both the *S. typhi* and *E. coli* homologs are reduced as the cultures reach their stationary phases ([Figure 4](#F4){ref-type="fig"}). Phylogenetic conservation and the reversely correlated expression profiles of npcRNA and mRNA strongly indicate that StyR-219 is involved in regulation of *prfB* expression. Figure 4.Expression analysis of *cis*-encoded antisense npcRNA candidates at different growth stages of *S. typhi* and *E. coli*. Northern blot analyses were performed on total RNA isolated from different growth stages of *S. typhi* and *E. coli* at different OD~600~ values, as shown at the top. OD~600~ 0.3: lag phase-steady bacterial growth; OD~600~ 0.7: log phase-exponential bacterial growth; and OD~600~ 1.5: stationary growth phase. The npcRNA candidates and RNA lengths are indicated. As loading controls, a few examples of ethidium bromide-stained 5S rRNA are shown.

### Subclass 2.2: npcRNA candidates antisense to the 5′-end of ORFs

The *cis*-encoded StyR-341 npcRNA candidate was located complementary to the ribosomal binding site (RBS) and translational start codon of the protein-coding gene *t2574*, which is restricted to *Salmonella* species and maps to SPI-6 ([Figure 7](#F7){ref-type="fig"}; [Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)), suggesting a function in *S. typhi* pathogenicity. In bacteria, npcRNAs exhibiting complementarities to mRNA regions involved in translation initiation, such as RBSs and AUG start codons, are obvious candidates for control at the level of translation regulation. Therefore, StyR-341 might be an example of a riboregulator that is associated with virulence gene control.

### Subclass 2.3: npcRNA candidates antisense to the 5′- and 3′-ends of two different ORFs

Two *cis*-encoded antisense npcRNA candidates (StyR-150 and StyR-328) are transcribed such that they are partially complementary to the 5′- and 3′-ends of two neighboring ORFs, as well as to the corresponding UTRs and the entire intergenic region ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). StyR-328 is complementary to the RBS plus AUG start codon of the *fdhE* gene and the stop codon of the *fdoI* gene. Both protein-coding genes are involved in formate metabolism. In addition to molecular oxygen, *Salmonella* can utilize formate dehydrogenase-*O* under aerobic conditions as an alternative terminal electron acceptor to generate a proton motive force ([@B57]). The physiological role of formate dehydrogenase-*O* is to ensure rapid adaptation during a sudden shift from aerobiosis to anaerobiosis to compensate for low levels of formate dehydrogenase-*N* ([@B57]). Formate dehydrogenase-O shares sequence similarity and immunological properties with the anaerobically expressed formate dehydrogenase-*N.* StyR-328 might possibly regulate bacterial adaptation to anaerobic conditions. This might partially explain our failure to detect the mature npcRNA during the examined growth stages of *S. typhi* under aerobic conditions.

### Subclass 2.4: cis-encoded antisense npcRNA candidates complementary to ORFs

Thirty-one npcRNA candidates belong to a subclass of *cis*-encoded antisense RNA species that are complementary to internal parts of the ORFs of known or hypothetical protein-coding genes ([Table 2](#T2){ref-type="table"}; [Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). StyR-243 (135 nt) is expressed in an antisense orientation to ORF of the *oxyR* gene, which encodes a DNA binding, transcriptional dual regulator of the LysR family ([@B58]). The gene encoding StyR-243 is highly conserved in all *Salmonella* species with a predicted putative homolog in *E. coli* (EcoR-243, 83% sequence similarity). OxyR participates in controlling several genes involved in the response to oxidative stress and the production of surface proteins by activating the expression of several genes (*e.g. dps*, *fur* and *katG*) whose protein products regulate intracellular hydrogen peroxide levels ([@B59; @B60; @B61]). *oxyR* is negatively autoregulated and its expression decreases towards the stationary growth phase ([@B58]). Interestingly, under aerobic growth conditions, StyR-243 expression significantly increases during the log phase and decreases in the stationary phase ([Figure 4](#F4){ref-type="fig"}; [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). In contrast, we did not detect expression of the putative EcoR-243 homolog in *E. coli*.

StyR-248 (211 nt) is located antisense to part of the *tus* ORF, which encodes the DNA replication terminus (ter) site binding protein. Tus, also known as *ter*-binding protein (TBP), binds to *ter* sites, blocking the progress of DNA replication in a polar fashion by blocking the progress of the helicase DnaB, eventually leading to replication termination ([@B62; @B63; @B64]). The *ter*-bound Tus also blocks the activity of helicases PriA, Rep and UvrD ([@B65]). StyR-248 is predominantly expressed in the stationary phase ([Figure 4](#F4){ref-type="fig"}). This might well reflect its possible role in the control of *tus* gene expression and replication of the *S. typhi* bacterial chromosome. The RNA is highly conserved in all published *Salmonella* species genomes with a putative homolog in *E. coli* (EcoR-248, 75% sequence similarity). Inexplicably, StyR-248 gives a signal of only ∼80 nt on northern blots ([Figure 4](#F4){ref-type="fig"}). Interestingly, StyR-248 forms a complex with the *S. typhi* Hfq protein *in vitro*, implicating this npcRNA as a potential riboregulator ([Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1) and [Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)).

StyR-264 (85 nt) is expressed complementary to part of the ORF of the *ung* gene that encodes the ubiquitous uracil-DNA glycosylate, an enzyme that prevents mutagenesis by eliminating uracil from DNA molecules by cleaving the *N*-glycosylic bond and initiating the base-excision repair pathway ([@B66]). The expression of StyR-264 was slightly decreased during the late growth stage of *S. typhi* ([Figure 4](#F4){ref-type="fig"}). Expression of the *ung* gene was reported to remain constant up to the early stationary phase of *E. coli* and to decline in the late stationary phase ([@B67]). Interestingly, the EcoR-264 homolog (85 nt) exhibits a similar expression pattern ([Figure 4](#F4){ref-type="fig"}), suggesting that the npcRNA might play a role in stabilizing Ung mRNA.

To gain further insight into the functional significance of other members of this subclass of antisense npcRNAs, we investigated their differential expression profiles and those of the corresponding mRNAs at various growth stages of *S. typhi* using real-time PCR ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Most of the sense--antisense pairs exhibited positively co-regulated expression profiles, indicating a possible involvement of antisense npcRNA in stabilizing *cis*-encoded mRNAs, probably enhancing their translation ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)).

Class 3: multicopy npcRNAs in *S. typhi*
----------------------------------------

We considered npcRNA candidates that were represented by more than one copy in the *S. typhi* genome to be repetitive ([Table 3](#T3){ref-type="table"}). Repetitive npcRNAs have been reported in all three domains of life. For example, four dispersed long-direct-repeat (LDR) sequences express both mRNAs (*ldrA-D*, where the designations A to D represent four different locations in the *E. coli* genome) encoding a toxic peptide and their *cis*-encoded antisense riboregulators, rdlA-D ([@B68]). In addition, six regions in the *E. coli* genome display high sequence similarity to the plasmid *hok/sok* loci encoding Sok npcRNAs controlling the sense-orientated protein-coding *hok* genes ([@B69]). We identified 11 repetitive npcRNA candidates. Eight originated from intergenic regions and the other three were transcribed in antisense orientations to *bona fide* or hypothetical genes. Seven of these repetitive npcRNAs exhibited growth stage-specific expression patterns ([Figure 5](#F5){ref-type="fig"}A and B). Table 3.Compilation of repetitive npcRNA candidates in *S. typhi*npcRNAscDNA (nt)RepeatsPresence *E. coli*N. Blot *S. typhi* /*E. coli*Growth reg. *S. typhi* /*E. coli*CommentsAcc. No.Intergenic repetitive npcRNAs    StyR-2410226×No−/−−/−Downstream from ORF of IS*200* transposaseFJ746424    StyR-441097×Yes+/++/+Part of ribosomal operonFJ746425    StyR-18484\>22×Yes−/−−/−FJ746429    StyR-19583\>30×Yes+/+−/−FJ746430    StyR-2071222×Yes+/++/−FJ746431    StyR-327538×No+/−+/−FJ746433    StyR-329120\>20×Yes+/−−/−FJ746434    StyR-215627×Yes+/++/+Upstream to ribosomal operonFJ746432Antisense repetitive npcRNAs    StyR-90902×Yes+/−+/−FJ746426    StyR-10310826×No+/−+/−Antisense to ORF of IS*200* transposaseFJ746427    StyR-137462×Yes+/−+/−Derived from SPI-7FJ746428[^5]

StyR-207 perfectly matches an *S. typhi* locus upstream from hypothetical protein-coding gene *t3891*, and at the same time is complementary to the *S. typhi t3892* pseudogene ([Figure 5](#F5){ref-type="fig"}A-c). Based on sequence similarities to *E. coli*, these two *S. typhi* ORFs might represent *S. typhi ldrD* and *rdl*D genes, respectively ([Figure 5](#F5){ref-type="fig"}A-c and B)*.* Moreover, a sequence similar to StyR-207 was detected in the *S. typhi* genome that was complementary to the hypothetical ORF *t2451* ([Figure 5](#F5){ref-type="fig"}A-d). *S. typhi* ORF *t2451* can be aligned to the *E. coli ldrB and rdlB* gene pair (71% sequence similarity; [Figure 5](#F5){ref-type="fig"}A-d). In *E. coli*, StyR-207 homologs (EcoR-207) are present in four copies complementary to *rdlA-rdlD* npcRNA genes. Therefore, StyR-207 npcRNAs might represent *cis*-encoded riboregulators for rdl npcRNAs, and thereby play a role in the ldr/rdl toxin--antitoxin system. Figure 5.Schematic representations and expression analyses of *S. typhi* repetitive npcRNA candidates. (**A**) Schematic representations of *S. typhi* repetitive npcRNA candidates. Coordinates of depicted genes are based on the completed genome of *S. typhi* Ty2 (AE014613). Locations of npcRNA candidates are depicted by red arrows. Known or predicted hypothetical genes are indicated with light blue arrows. Drawings are not to scale. StyR-24 and StyR-103 npcRNA candidates are each repeated 24 times in the *S. typhi* genome; only a schematic representation is shown. StyR-44 and StyR-215 are each repeated seven times in the *S. typhi* genome; only two rRNA operons are shown (**a**, **b**). StyR-207 and its schematic representation is depicted in (**c**); green arrow indicates putative *S. typhi rdl* npcRNA gene (annotated in this study). StyR-207a npcRNA (**d**) was predicted based on sequence similarity, putative *ldr* and *rdl* genes (annotated in this study) are depicted by blue and green arrows, respectively. (**B**) Northern blots showing expression patterns of repetitive npcRNA candidates at different growth stages of *S. typhi* and *E. coli*. OD~600~ values are indicated across the tops of the blots. OD~600~ 0.3: lag phase-steady bacterial growth; OD~600~ 0.7: log phase-exponential bacterial growth; and OD~600~ 1.5: stationary growth phase. The npcRNA candidates and RNA lengths are indicated. As loading controls, a few examples of ethidium bromide-stained 5S rRNA are shown.

StyR-44 and StyR-215 are derived from ribosomal operons and are each repeated seven times in the *S. typhi* and *E. coli* genomes. Based on the tRNA genes located in the internal spacer region between 16S and 23S rRNAs, there are two subtypes of ribosomal RNA operons defined in many bacterial species ([Figure 5](#F5){ref-type="fig"}A-a and -b). One subtype features tRNA-Glu and the second tRNA-Ile and tRNA-Ala in the spacer ([@B70]). StyR-44 (109 nt) is located upstream of the respective 23S rRNA genes in all rRNA operons. StyR-215 (62 nt) is located 123 nt upstream from the 16S rRNA gene in all seven ribosomal RNA operons ([Figure 5](#F5){ref-type="fig"}A-a and -b). StyR-44 and StyR-215 are both growth rate-regulated and processed from longer precursors ([Figure 5](#F5){ref-type="fig"}B). At this point, we cannot rule out the possibility that both RNAs are merely metastable RNA intermediates generated during maturation of ribosomal RNA. Conspicuously, although StyR-215 was cloned from *S. typhi*, a northern blot signal was only detected in *E. coli* ([Figure 5](#F5){ref-type="fig"}B).

StyR-24 and StyR-103 are both derived from the repetitive IS*200* transposon ([Figure 5](#F5){ref-type="fig"}A), of which there are 24 copies in *S. typhi*. StyR-24 is located 4 nt downstream of the ORF of the transposase gene in the same orientation, whereas StyR-103 is expressed antisense to the transposase ORF ([Figures 5](#F5){ref-type="fig"}A, B and [7](#F7){ref-type="fig"}). RNA-OUT, a *cis-*endoded antisese npcRNA to the ORF of the IS*10* transposase-encoded gene (RNA-IN), was previously shown to regulate transposase expression and control transposition activity in *E. coli* ([@B71]). StyR-103 represents an abundantly expressed RNA species with pronounced upregulation during the exponential growth phase ([Figure 5](#F5){ref-type="fig"}B). Therefore, similar to RNA-OUT, StyR-103 npcRNA may act as a *cis*-encoding antisense npcRNA to regulate transposase expression and influence the rate of transposition of IS*200* elements. This may be the reason for the extremely low transposition frequency of IS*200* during *S. typhi* growth ([@B72]). Indeed, *cis*-encoded antisense npcRNA regulation of transposition activity is a widespread phenomenon in prokaryotes ([@B52]).

Class 4: *S. typhi* npcRNAs overlapping with ORFs in the sense orientation
--------------------------------------------------------------------------

Twenty-three npcRNA candidates were transcribed in the same orientation as ORFs and were partially congruent with the corresponding mRNAs ([Table 4](#T4){ref-type="table"}). The *E. coli* t44 npcRNA (135 nt) ([@B51]) maps upstream of the 30S ribosomal protein S2 gene, *rpS2*, suggesting its role in attenuating *rpS2* expression. StyR-7 appears to be a putative *S. typhi* counterpart of the *E. coli* t44 npcRNA; however, cDNAs for StyR-7 are up to 238 nt long (103 nt longer than t44) covering the *S. typhi rpS2* translational start codon and part of the N-terminus of the ORF ([Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)). Table 4.Compilation of npcRNA candidates overlapping with ORFs in sense orientationnpcRNAscDNA (nt)Orient.Overlap (nt)Gene IDPresence in *E. coliN. blot S. typhi / E. coli*Growth reg., S. *typhi* / *E. coli*SpecificityCommentsAcc. No.Partially overlapping with 5′-end of ORF    StyR-9145\>111071490No+/−+/−*S. typhi,S. para C*FJ746436    StyR-15306\>1291070087Yesndnd*Sal.* sp*.*FJ746437    StyR-29245\<1161067535Yes+/++/−FJ746440    StyR-64108\<301071363YesndndFJ746443    StyR-77114\>491069758YesndndFJ746446    StyR-8477\<81067059YesndndFJ746447    StyR-145327\>1081069487Nondnd*S. typhi,S. para* CFJ746448    StyR-228111\>21070302No−/−−/−*Sal.* sp*.*FJ746452    StyR-255243\>1001067871Yes−/−−/−FJ746453    StyR-28286\>721068122YesndndFJ746457    StyR-296293\>711069730Yes+/++/+FJ746454    StyR-335263\<971069119Yes−/−−/−FJ746455    StyR-364176\>771067975YesndndFJ746456Partially overlapping with 3′-end of ORF    StyR-6159\>1121068275YesndndFJ746435    StyR-26223\<1501067805YesndndFJ746438    StyR-27146\>291071267No+/−+/−FJ746439    StyR-5187\>41067741Yes+/++/+FJ746441    StyR-6895\>431068476YesndndFJ746444    StyR-7487\<121069270Yesndndρ-ind. term.FJ746442    StyR-76241\>1121069147YesndndFJ746445    StyR-14983\>191070930Nondnd*Sal.* sp*.*FJ746449    StyR-165105\>401069332YesndndFJ746450    StyR-19271\>331071394Yesndndρ-ind. term.FJ746451[^6]

Northern blot analyses revealed growth stage-specific expression for five of the novel npcRNA candidates in this category ([Figure 6](#F6){ref-type="fig"}). StyR-29 represents another example of an npcRNA candidate that overlaps the area of the 5′-UTR and a portion of the ORF of the *rpsT* ribosomal protein S20 coding gene. Expression of StyR-29 is a bit complex, as the start of transcription is located further upstream and complementarily to the hypothetical t0046 ORF. StyR-29 expression analysis revealed three distinct transcripts of 77 nt, 140 nt and 245 nt ([Figure 6](#F6){ref-type="fig"}). Our cDNA library contains the longest (245 nt). The 245 nt and 77 nt transcripts were specific to the stationary phase of *S. typhi* growth. In contrast, the 140-nt RNA fragment was present throughout all the growth stages in both *S. typhi* and *E. coli* ([Figure 6](#F6){ref-type="fig"}). Therefore, the three forms of StyR-29 might regulate expression in multiple modes. Figure 6.Northern blots showing growth-dependent expression patterns of *S. typhi* npcRNA candidates that partially overlap with ORFs of protein-coding genes. Growth stages of *S. typhi* and *E. coli*. OD~600~ values are indicated across the tops of the blots. OD~600~ 0.3: lag phase-steady bacterial growth; OD~600~ 0.7: log phase-exponential bacterial growth; and OD~600~ 1.5: stationary growth phase. The npcRNA candidates and RNA lengths are indicated. As loading controls, a few examples of ethidium bromide-stained 5S rRNA are shown.

npcRNAs from the *S. typhi* Pathogenicity Islands
-------------------------------------------------

The emergence of pathogenic strains of enteric bacteria and their adaptation to new environments is accompanied by the acquisition of foreign DNA segments termed 'genetic islands'. These islands are arranged as clusters of genes and encode virulence determinants ([@B11],[@B14]). Of the 97 novel npcRNA candidates discussed, 10 mapped to SPI regions, suggesting that they might have various unknown virulence-associated functions ([Figure 7](#F7){ref-type="fig"}). Figure 7.Schematic representations of SPI-derived npcRNA candidates. Coordinates are based on the *S. typhi* Ty2 complete genome annotation (AE014613). Locations of npcRNA candidates are indicated by red arrows. ORFs of known or hypothetical genes are indicated by light blue arrows. SPI-numbers are indicated. Drawings are not to scale.

StyR-327 is located in the intergenic region between *ssaE* and *sseA* of SPI-2 ([Figure 7](#F7){ref-type="fig"}). Sequences similar to this intergenic region exist in multiple copies in *Salmonella* and *E. coli* species (at least six times in *Salmonella* species). We detected terminal A+T-rich inverted repeat sequences flanking these regions; therefore, the intergenic region harboring StyR-327 might represent a possible miniature inverted repeat transposable element (MITE) in bacterial genomes ([@B73]). The *S. typhi* SPI-3 harbors an additional copy of such an intergenic MITE with sequence similarity to StyR-327 ([Figure 7](#F7){ref-type="fig"}). Northern blot analysis indicated a growth stage-specific expression of StyR-327 ([Figure 5](#F5){ref-type="fig"}B). Bacterial MITE sequences are predominantly found in intergenic regions carrying regulatory elements or even short ORFs fused to pre-existing genes, potentially changing their regulation or function ([@B73]). Thus, StyR-327 might be a functional riboregulator within a bacterial MITE sequence.

In addition to three putative npcRNAs in SPI-5 (StyR-24 and StyR-103) and SPI-6 (StyR-341), we identified six npcRNAs candidates in SPI-7 (StyR-9, StyR-101, StyR-137, StyR-143, StyR-161 and StyR-381). StyR-9 overlaps with the translational start codon of the hypothetical protein gene *t4341*, and northern blot analysis showed growth stage-specific expression ([Figure 6](#F6){ref-type="fig"}). The RNA shares 89% sequence similarity with StyR-10, the latter being conserved in *E. coli.* StyR-9 may be a paralog of StyR-10, having originated via genomic duplication. Interestingly, the two npcRNA candidates show different expression patterns ([Figures 2](#F2){ref-type="fig"} and [6](#F6){ref-type="fig"}) and both form specific RNP complexes with the *S. typhi* Hfq protein ([Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1) and [Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkq281/DC1)), further indicating that they might function as riboregulators. StyR-101 and StyR-137 are *cis*-encoded in the antisense orientation to ORFs *t4228* and *t4317*, respectively, suggesting possible functions in regulating these genes. StyR-161 is restricted to *S. typhi* and *S. paratyphi* C and its transcription is growth stage-regulated ([Figure 2](#F2){ref-type="fig"}). StyR-381 is constitutively expressed and restricted to *S. typhi* and *S. dublin* ([Figures 2](#F2){ref-type="fig"} and [7](#F7){ref-type="fig"}). These observations suggest that npcRNAs are prominently represented in and expressed from pathogenic islands of the bacteria and have potentially different functions related to virulence.

CONCLUSION
==========

We present an experimental survey of the small npcRNA transcriptome in *S. typhi* that causes typhoid fever. Ninety-seven novel npcRNA candidates were identified and characterized. Northern blot analyses identified 33 npcRNA candidates that were differentially expressed during *S. typhi* growth. ρ-Independent transcription terminators and/or promoters were predicted for 10 of the putative npcRNAs. Most of the npcRNAs were derived from intergenic ([@B24]) or antisense ORF ([@B39]) regions. Phylogenetic analysis predicted that 63 of the novel putative npcRNA candidates had homologs in *E. coli*. Northern blot signals supported the phylogenetic predictions for 19 of these npcRNA homologs, further implicating their functional significance. On the other hand, three npcRNA candidates were specific to *S. typhi*, while 22 were restricted to *Salmonella* strains. Some of these candidates are potentially involved in host-specific pathogenicity. Furthermore, we identified 10 SPI-derived npcRNA candidates that might be involved in regulatory mechanisms of virulence, antibiotic resistance pathways or the pathogenic specificity of *S. typhi*. Eleven npcRNA candidates were of repetitive origin, including possible riboregulators for transposase and toxin/antitoxin related genes. Thirty-nine of the *cis*-encoded npcRNA candidates were transcribed in the antisense orientation to ORFs of protein-coding genes, further supporting previous observations of widespread sense--antisense regulatory networks in bacteria. We also detected small stable npcRNAs candidates overlapping with the 5′-UTRs of a number of ribosomal protein-coding genes (individual or organized in an operon). This could point to an additional layer of regulation during ribosome biogenesis. *In vitro* binding assays showed that six of the npcRNA candidates, representing different subgroups, interacted with the *S. typhi* Hfq protein, further supporting an important role of Hfq in npcRNA regulatory networks.

A particularly interesting case is StyR-3 that shares the promoter region with the *ramA* gene. We show that RamR, the transcriptional repressor protein of *ramA*, interacted with both the promoter region of *ramA* and StyR-3 npcRNA. The RNP complex was formed with an apparent K50 of about 300 nM, similar to that of the observed DNP complex. Moreover, StyR-3 specifically competed with RamR protein from the DNP complex. These findings point to a potential function of StyR-3 npcRNA in regulating *ramA* gene expression, which is associated with MDR in *S. typhi*. Our findings set the stage for further experimentation, to confirm the functions of numerous novel npcRNA candidates in the pathogenesis of *S. typhi* and its interactions with its human host cells.
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